Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LVIII.o

Path: Diffuse alveolar damage (DAD-pattern) (see also IL)

Publications

Mikkelsen LF, Rubak S

Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment.

BMC pulmonary medicine 2020 Nov 26;20;313 — 2020 Nov 26 — 313

Browning ET, Huckleberry JM, Barrow WB, Restauri NL, Kemme DJ, Cool CD, Weyant MJ, Franklin WA, Camidge DR

Downstaging of Non-Small-Cell Lung Cancer Through Identification of Reversible Drug Toxicity.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Jan 10;34;e6-8 — 2016 Jan 10 — e6-8

Taskinen E, Tukiainen P, Sovijarvi AR

Nitrofurantoin-induced alterations in pulmonary tissue. A report on five patients with acute or subacute reactions.

Acta pathologica et microbiologica Scandinavica. Section A, Pathology 1977 Sep;85;713-20 — 1977 Sep — 713-20